Literature DB >> 33496230

Role of Burkholderia pseudomallei-Specific IgG2 in Adults with Acute Melioidosis, Thailand.

Panjaporn Chaichana, Kemajittra Jenjaroen, Suchintana Chumseng, Manutsanun Sumonwiriya, Patpong Rongkard, Barbara Kronsteiner, Prapit Teparrukkul, Direk Limmathurotsakul, Nicholas P J Day, Narisara Chantratita, Susanna J Dunachie.   

Abstract

Melioidosis is a life-threatening infectious disease caused by the gram-negative bacillus Burkholderia pseudomallei. An effective vaccine is needed, but data on protective immune responses in human melioidosis are lacking. We used ELISA and an antibody-dependent cellular phagocytosis assay to identify the major features of protective antibodies in patients with acute melioidosis in Thailand. We found that high levels of B. pseudomallei-specific IgG2 are associated with protection against death in a multivariable logistic regression analysis adjusting for age, diabetes, renal disease, and neutrophil count. Serum from melioidosis survivors enhanced bacteria uptake into human monocytes expressing FcγRIIa-H/R131, an intermediate-affinity IgG2-receptor, compared with serum from nonsurvivors. We did not find this enhancement when using monocytes carrying the low IgG2-affinity FcγRIIa-R131 allele. The findings indicate the importance of IgG2 in protection against death in human melioidosis, a crucial finding for antibody-based therapeutics and vaccine development.

Entities:  

Keywords:  Burkholderia pseudomallei; FcγRIIA; H131; IgG subclasses; IgG2 subclass; R131; Thailand; antibodies; antimicrobial resistance; bacteria; bacterial infection; melioidosis; polymorphism

Mesh:

Substances:

Year:  2021        PMID: 33496230      PMCID: PMC7853568          DOI: 10.3201/eid2702.200213

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  34 in total

1.  Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.

Authors:  Patcharaporn Tippayawat; Maneerat Pinsiri; Darawan Rinchai; Donporn Riyapa; Amornrat Romphruk; Yunn-Hwen Gan; Raymond L Houghton; Philip L Felgner; Richard W Titball; Mark P Stevens; Edouard E Galyov; Gregory J Bancroft; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

2.  Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia.

Authors:  A M Yee; H M Phan; R Zuniga; J E Salmon; D M Musher
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

3.  Antilipopolysaccharide II: an antibody protective against fatal melioidosis.

Authors:  C Charuchaimontri; Y Suputtamongkol; C Nilakul; W Chaowagul; P Chetchotisakd; N Lertpatanasuwun; S Intaranongpai; P J Brett; D E Woods
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

4.  Opsonophagocytic activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement.

Authors:  A Aase; T E Michaelsen
Journal:  Scand J Immunol       Date:  1994-06       Impact factor: 3.487

5.  Distribution of immunoglobulin classes and IgG subclasses against a culture filtrate antigen of Burkholderia pseudomallei in melioidosis patients.

Authors:  V Chenthamarakshan; M V Kumutha; J Vadivelu; S D Puthucheary
Journal:  J Med Microbiol       Date:  2001-01       Impact factor: 2.472

6.  Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis.

Authors:  Michelle Nelson; Joann L Prior; M Stephen Lever; Helen E Jones; Timothy P Atkins; Richard W Titball
Journal:  J Med Microbiol       Date:  2004-12       Impact factor: 2.472

7.  Short report: Melioidosis in Myanmar: forgotten but not gone?

Authors:  Vanaporn Wuthiekanun; Sayan Langa; Witaya Swaddiwudhipong; Wilarat Jedsadapanpong; Yingyot Kaengnet; Wirongrong Chierakul; Nicholas P Day; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

8.  Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand.

Authors:  W Chaowagul; N J White; D A Dance; Y Wattanagoon; P Naigowit; T M Davis; S Looareesuwan; N Pitakwatchara
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

9.  T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients.

Authors:  Kemajittra Jenjaroen; Suchintana Chumseng; Manutsanun Sumonwiriya; Pitchayanant Ariyaprasert; Narisara Chantratita; Piyanate Sunyakumthorn; Maliwan Hongsuwan; Vanaporn Wuthiekanun; Helen A Fletcher; Prapit Teparrukkul; Direk Limmathurotsakul; Nicholas P J Day; Susanna J Dunachie
Journal:  PLoS Negl Trop Dis       Date:  2015-10-23

10.  Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis.

Authors:  Mary N Burtnick; Teresa L Shaffer; Brittany N Ross; Laura A Muruato; Elena Sbrana; David DeShazer; Alfredo G Torres; Paul J Brett
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

View more
  5 in total

1.  Melioidosis Patient Survival Correlates With Strong IFN-γ Secreting T Cell Responses Against Hcp1 and TssM.

Authors:  Sineenart Sengyee; Atchara Yarasai; Rachan Janon; Chumpol Morakot; Orawan Ottiwet; Lindsey K Schmidt; T Eoin West; Mary N Burtnick; Narisara Chantratita; Paul J Brett
Journal:  Front Immunol       Date:  2021-07-30       Impact factor: 7.561

2.  The Epidemiology of Melioidosis and Its Association with Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Sukanta Chowdhury; Lovely Barai; Samira Rahat Afroze; Probir Kumar Ghosh; Farhana Afroz; Habibur Rahman; Sumon Ghosh; Muhammad Belal Hossain; Mohammed Ziaur Rahman; Pritimoy Das; Muhammad Abdur Rahim
Journal:  Pathogens       Date:  2022-01-25

3.  Evaluation of two different vaccine platforms for immunization against melioidosis and glanders.

Authors:  Sergei S Biryukov; Christopher K Cote; Christopher P Klimko; Jennifer L Dankmeyer; Nathaniel O Rill; Jennifer L Shoe; Melissa Hunter; Zain Shamsuddin; Ivan Velez; Zander M Hedrick; Raysa Rosario-Acevedo; Yuli Talyansky; Lindsey K Schmidt; Caitlyn E Orne; David P Fetterer; Mary N Burtnick; Paul J Brett; Susan L Welkos; David DeShazer
Journal:  Front Microbiol       Date:  2022-08-17       Impact factor: 6.064

4.  Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC.

Authors:  Lindsey K Schmidt; Caitlyn E Orne; Teresa L Shaffer; Shane M Wilson; Nittaya Khakhum; Alfredo G Torres; Paul J Brett; Mary N Burtnick
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

5.  Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed TH1-TH17 Immunity, Correlated with Increased Protection against Burkholderia pseudomallei.

Authors:  Daniel Tapia; Javier I Sanchez-Villamil; Heather L Stevenson; Alfredo G Torres
Journal:  mBio       Date:  2021-06-29       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.